AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $850,683 | -15.8% | 46,460 | -0.9% | 0.00% | 0.0% |
Q2 2023 | $1,010,813 | -28.7% | 46,862 | -3.0% | 0.00% | -50.0% |
Q1 2023 | $1,417,739 | +66.6% | 48,321 | +109.8% | 0.00% | +100.0% |
Q4 2022 | $851,033 | +31.1% | 23,032 | -0.1% | 0.00% | 0.0% |
Q3 2022 | $649,000 | – | 23,045 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 5,472,033 | $154,038,000 | 4.47% |
Ghost Tree Capital, LLC | 550,000 | $15,483,000 | 4.35% |
Ghost Tree Capital, LLC | 500,000 | $14,075,000 | 3.95% |
Bain Capital Life Sciences Investors, LLC | 1,023,214 | $28,803,000 | 3.44% |
Boxer Capital, LLC | 2,084,000 | $58,665,000 | 3.30% |
Alpha Wave Global, LP | 700,635 | $19,723,000 | 2.33% |
Soleus Capital Management, L.P. | 429,336 | $12,086,000 | 1.64% |
Ikarian Capital, LLC | 250,000 | $7,037,000 | 1.40% |
Cormorant Asset Management, LP | 610,000 | $17,172,000 | 1.20% |
SECTORAL ASSET MANAGEMENT INC | 205,400 | $5,782,000 | 1.14% |